The cost-utility analysis for the treatment of pediatric femoral shaft fracture Authors: Theeranop Temtheerakij, Chanika Angsanuntsukh, Oraluck Pattanaprateep, Thira Woratanarat, Patarawan Woratanarat Published: 2025 ABSTRACT BackgroundHip spica cast, plate and screw fixation, elastic nail fixation and external fixation are used to manage femoral fractures in children. Currently, there is still lacking evidence of the full economic evaluation for various treatments of pediatric femoral shaft fractures. This study was aimed to determine the cost-utility for the pediatric femoral shaft fracture treatment methods.MethodsA bidirectional cohort study included children aged 2–11 years old with femoral shaft fracture at the university hospital between January 2001 and December 2021. Direct medical and non-medical costs were retrieved from medical records and telephone interview, while quality adjusted life year (QALY) was derived from EQ-5D-5L questionnaire. Considering both hospital and societal perspective, cost-utility analysis was assessed by incremental cost-effective ratio (ICER). The one-way sensitivity analysis was done according to varying parameters, and a Tornado diagram was generated.ResultsTwelve patients were included with mean age 7.6 ± 3.1 years, and 7 females (58.3%). Treatment distributions were 3 (25%) hip spica (HS), 8 (66.7%) plate and screws (PS), and one (8.3%) external fixation (EF). Regarding HS vs. PS, QALY was 0.981 vs. 0.958 (P = 0.393), and the leg length discrepancy was 8.3 mm vs. 8.0 mm (P = 0.903). Direct medical cost was 28,465 vs. 37,277 Baht (P = 0.047), and direct non-medical cost was 100,000 vs. 97,250 Baht (P = 0.570). When compared to PS, HS had lower ICER for hospital perspective − 383,152 Baht/QALY and for societal perspective − 263,587 Baht/QALY. Admission, and PS operation cost mostly contributed to cost-utility pattern.ConclusionHS provides cost-utility advantages for the treatment of pediatric femoral shaft fractures when compared to PS. Small samples for each treatment, especially EF, comes up with insufficient power to detect significant difference between groups. Further comprehensive study including other operations with adequate sample size is required. Background A pediatric femoral shaft fracture is primarily caused by falls from heights, traffic accidents [1–3], and stress fracture [4–6]. This problem occurs less than 2% of all bony injuries in children, particularly in boys aged 1–3 years old, and adolescence [1–3]. Available therapeutic approaches include harness, hip spica, traction and casting, titanium elastic nail (TENs), submuscular or dynamic compression plating, and external fixation. Age and nature of fractures are key factors for proper treatment selection [7]. With regards to femoral shaft fractures between aged 2–11 years, TENs seem to be the best procedure in terms of union, joint stiffness, malunion and infection rates [8]. However, nailing may come with several disadvantages, i.e., loss of reduction, nonunion, refracture [9], prolonged hospitalization, demand of second operation for hardware removal, and financial burden [10] over other treatment methods. Choosing the proper cost-effective management for pediatric femoral fractures would lead to acceptable bone growth, ultimately ensuring a good quality of life [11–13], and reduce treatment expenses [7, 14]. Previous researches from high-income countries reported average total costs between 5,970 − 50,667 US dollars [15] for immediate hip spica ($5,970), hospital traction ($50,667), hospital with home traction ($30,667), and external fixation ($7,626) [15, 16]. Mean total hospital charges for nailing ($21,359 − 59,724) were significantly higher than those of hip spica ($5,494 − 19,208) [17, 18]. In lower middle-income economy, average costs of open reduction and dynamic compression plate fixation ($206) exceeded those from traction ($124) [19]. Unfortunately, neither studies analyzed cost-effectiveness nor considered quality of life. At present, the universal coverage scheme (UCS) in Thailand serves majority of population. According to limited annual capitation rate ($102 per person), the benefit packages specifically cover casting, traction, plate and screw, or external fixation. As healthcare schemes usually depend on budget allocations driven by national policy makers, healthcare professionals should take into account the economic benefits from societal perspective to select proper management. This bidirectional cohort study, therefore, aimed to evaluate cost-utility analysis of femoral shaft fracture treatments in children 2–11 years of age. Societal perspective costs, and utility by EQ-5D-5L were considered. Either hip spica cast or dynamic compression plating was hypothesized to provide the best cost-utility in our context of middle-income countries. Methods A bidirectional cohort was conducted at the quaternary-care university hospital between January 2001 and December 2021. After approval by Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital, Mahidol University (COA. MURA2021/617), eligible patients were identified through hospital electronic medical record system by searching for the children admitted with the diagnosis of fracture of shaft of femur (the International Statistical Classification of Diseases and Related Health Problems, tenth revision; ICD-10 code S72.3). Children aged 2–11 years who had femoral shaft fracture between January 2001 and June 2021 were then identified from the medical records. After completing informed consent/assent processes, both eligible patient with out-patient follow-up data and their parent/guardian who were willing to participate to the study were included in the study. Exclusion criteria comprised any pathologic fracture, metabolic bone disease, and follow-up less than 2 years. The interventions of interests were hip spica cast, plate and screws fixation, and external fixation. After admission, immediate hip spica cast was applied under general anesthesia and fluoroscopic guidance in the operative room. In contrast, plate and screws fixation was usually performed 1–2 days after admission or injury, whereas the external fixation was indicated for unstable or polytrauma patients. Demographic characteristics (such as age, sex, medical comorbidities), fracture types, and outcomes of interest (i.e., leg length discrepancy, malunion, and nonunion) were collected. Leg length discrepancy (in millimeters) was measured by clinical examination of true leg length and apparent leg length. A malunion is defined as a healed fracture in a deformed, malposition, and clinically unacceptable alignment [20]. Nonunion is an unhealed fracture, and lack of progressive radiographic callus formation for at least 6–9 months [21, 22]. Resource utilization consisted of operative time (min), blood loss (ml), blood transfusion (unit), length of hospital stays (day), and number of hospital visits (time). Direct medical cost encompassing the operation, admission, and radiographic investigation were obtained from medical records. Operation costs accounted for instruments (casts, plate and screws, external fixation), staffs (surgeons, nurses), anesthesia, operation, fluoroscopy, second or another operation, and multiplied by duration of each process. Admission costs (inpatient and outpatient hospital care) corresponded to drugs/medication, laboratory investigation, rehabilitation, staffs (physicians, physiotherapists, nurses). By parents’ telephone interview, direct non-medical costs incurred from transportation, caregiver, clothes, and food costs during femoral fracture treatment, indirect costs (work/school absence, opportunity costs) [23], willingness to pay, and EQ-5D-5L questionnaire [24] were retrieved by an orthopaedic trainee at least 2 years after the treatment. Any missing costs or EQ-5D-5L data was completed by recontacting the patients’ family and the hospital, where appropriate. Both direct medical and non-medical costs were converted from the inception period to the present value (year 2022) with an annual inflation rate of 3% per year in Thai Baht. The Inflation adjustment formula (cost x (1+ (inflation rate)number of year) was estimated as cost x (1.03)number of year. In case of the same medication, equipment, personnel, and healthcare expenditures, the present unit cost was directly applied. At two years of follow up, complete bone healing and bone remodeling process were assumed [25], and outcomes as well as quality of life were assessed. Statistical analysis Data were analyzed using STATA version 18.0, StataCorp, College Station, Texas, USA. Continuous variables were presented as means and standard deviation or median and range, and categorical variables were presented as percentages. To compare continuous data between groups, unpaired t-test or Mann-Whitney U test were used for normally and non-normally distributed data, respectively. A chi-square or Fisher’s exact test was used to determine significance in the case of binary or categorical data where appropriate. Tobit regression for the quality of life, and cost-utility analysis were performed in both healthcare provider and societal perspectives. For provider perspective, only direct medical cost was considered, while total costs were determined for societal perspective. Incremental cost-effectiveness ratio (ICER), then was estimated by conceiving the ratio of the different cost and utility. For example, the comparison between ICER of hip spica (HS) and plate and screw fixation (PS) was determined as \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:ICER=\:\frac{{Cost}_{\text{H}\text{S}}-{Cost}_{\text{P}\text{S}}}{{QALYS}_{\text{H}\text{S}}-{QALYS}_{\text{P}\text{S}}}$$\end{document} Utility was calculated from quality of life (QoL) in each dimension of EQ-5D-5L [24]. Quality adjusted life year (QALY) multiplied utility score by a one year period, based on growth disturbance lasted for 1–2 years and unaffected by the fracture type or residual angulation [26], One-way sensitivity analysis was carried out by varying the possible minimum and maximum value of parameters and plotted as Tornado diagram. Significant p-value was < 0.05. Sample size was estimated from the two independent means formula. The difference in the cost-utility between two treatment types was set at 10% of the cost/QALY threshold for Thailand (160,000 Thai Baht) [27], resulting in a difference of 16,000 Thai Baht, and standard deviation (SD) of 10,000 Thai Baht. With alpha error 0.05, power 0.8, seven participants per group was needed. Accounting for an estimated 10% loss to follow-up resulting in a final sample size of eight participants per treatment. Results According to search strategies, 49 cases were identified from the medical records, 37 of them were discarded due to osteogenesis imperfecta, or less than two years of follow-up. Only 12 patients met the inclusion and exclusion criteria. Average age was 7.6 ± 3.1 years, five males (41.7%) and seven females (58.3%). The most common type of fracture was transverse configuration (six patients, 50%). Distribution of treatments were three (25%) HS, eight (66.7%) PS and one (8.3%) external fixation (EF). The patient with EF had multiple injuries as head injury and other long bones fracture. HS showed slightly higher QoL (0.981 ± 0.032) when compared to PS (0.958 ± 0.046) without statistical difference (P = 0.393). The leg length discrepancy was 8.3 ± 2.9 mm in HS and 8.0 ± 5.8 mm in PS (P = 0.903). There was no malunion and non-union reported in this study (Table 1). Table 1Baseline characteristics and outcomesFactorsHip spica cast (n = 3)Plate and screw fixation (n = 8)P-valueExternal fixation (n = 1)Age (year), mean (SD)6.0 (1.0)8.6 (3.2)0.0724.0 (-)Male (%)1 (33.3)4 (50.0)1.0000Fracture (%)0.636 Transverse Spiral/oblique Comminution1 (33.0)2 (67.0)05 (62.5)2 (25.0)1 (12.5)001Quality of life (Utility score), mean (SD)0.981 (0.032)0.958 (0.046)0.3930.944 (-)LLD (mm), mean (SD)8.3 (2.9)8.0 (5.8)0.903-Malunion (%)00-0Nonunion (%)00-0SD = standard deviation, LLD = leg length discrepancy, P-value: comparing between hip spica cast and plate and screw fixation Table 1Baseline characteristics and outcomesFactorsHip spica cast (n = 3)Plate and screw fixation (n = 8)P-valueExternal fixation (n = 1)Age (year), mean (SD)6.0 (1.0)8.6 (3.2)0.0724.0 (-)Male (%)1 (33.3)4 (50.0)1.0000Fracture (%)0.636 Transverse Spiral/oblique Comminution1 (33.0)2 (67.0)05 (62.5)2 (25.0)1 (12.5)001Quality of life (Utility score), mean (SD)0.981 (0.032)0.958 (0.046)0.3930.944 (-)LLD (mm), mean (SD)8.3 (2.9)8.0 (5.8)0.903-Malunion (%)00-0Nonunion (%)00-0SD = standard deviation, LLD = leg length discrepancy, P-value: comparing between hip spica cast and plate and screw fixation Baseline characteristics and outcomes Transverse Spiral/oblique Comminution 1 (33.0) 2 (67.0) 0 5 (62.5) 2 (25.0) 1 (12.5) 0 0 1 SD = standard deviation, LLD = leg length discrepancy, P-value: comparing between hip spica cast and plate and screw fixation Resource utilization and costs were shown in Table 2. HS had significant shorter operative time (P = 0.003), blood loss (P < 0.001), and operation cost (P = 0.002) than PS. HS also tended to have lower blood transfusion, shorter hospital stays, fewer hospital visits, less admission costs, x-ray film costs, and caregiver costs as well as willingness to pay when compared to PS. Direct medical costs of HS (28,465 ± 5,789 Baht) were lower than those of PS (37,277 ± 6,822 Baht), P = 0.095. HS mainly contributed to transportation, and clothes-foods costs leading to high direct non-medical costs without significant difference between groups (HS 100,000 ± 5,000 Baht, and PS 97,250 ± 42,060 Baht). EF seemed to utilize less resources, but consumed longer length of hospital stays with higher costs than PS. Table 2Resource utilization and costs for each treatmentFactors, mean (SD)Hip spica cast(n = 3)Plate and screw fixation (n = 8)P-valueExternal fixation (n = 1)Operative time (min)65.0 (8.7)145.0 (52.1)0.003*65.0 (-)Blood loss (ml)0 (0)335.0 (148.1)< 0.001*50.0 (-)Blood transfusion (unit)0 (0)0.4 (0.5)1.0000 (-)Length of hospital stay (day)6.3 (4.0)6.8 (1.5)0.87613.0 (-)Number of visits (time)10.7 (0.6)11.1 (1.9)0.55410.0 (-)Operation costs (Baht)11,615.0 (212.2)18,862.9 (4,266.1)0.002*21,400.0 (-)Admission costs (Baht)22,631.7 (6,072)30,840.0 (5,825.9)0.12443,500.0 (-)Film X-ray costs (Baht)5,833.3 (577.4)6,437.5 (1,083.6)0.2726,500.0 (-)Transportation costs (Baht)30,000.0 (5,000.0)17,875.0 (9,657.5)0.029*25,000.0 (-)Caregiver costs (Baht)40,000.0 (10,000.0)55,000.0 (29,760.9)0.24370,000.0 (-)Clothes-foods costs (Baht)30,000.0 (10,000.0)24,375.0 (10,500.9)0.46150,000.0 (-)Willingness to pay (Baht)60,000.0 (10,000.0)137,500.0 (148,203.5)0.184200,000.0 (-)Direct medical cost (Baht)28,465.0 (5,789.4)37,277.5 (6,822.1)0.09550,000.0 (-)Direct non-medical and indirect costs (Baht)100,000.0 (5,000.0)97,250.0 (42,060.3)0.861145,000.0 (-)Total costs (Baht)128,465.0 (10,496.1)134,527.5 (41,799.0)0.713195,000.0 (-)SD = standard deviation, *significant P-value < 0.05 comparing between hip spica and plate and screw fixation Table 2Resource utilization and costs for each treatmentFactors, mean (SD)Hip spica cast(n = 3)Plate and screw fixation (n = 8)P-valueExternal fixation (n = 1)Operative time (min)65.0 (8.7)145.0 (52.1)0.003*65.0 (-)Blood loss (ml)0 (0)335.0 (148.1)< 0.001*50.0 (-)Blood transfusion (unit)0 (0)0.4 (0.5)1.0000 (-)Length of hospital stay (day)6.3 (4.0)6.8 (1.5)0.87613.0 (-)Number of visits (time)10.7 (0.6)11.1 (1.9)0.55410.0 (-)Operation costs (Baht)11,615.0 (212.2)18,862.9 (4,266.1)0.002*21,400.0 (-)Admission costs (Baht)22,631.7 (6,072)30,840.0 (5,825.9)0.12443,500.0 (-)Film X-ray costs (Baht)5,833.3 (577.4)6,437.5 (1,083.6)0.2726,500.0 (-)Transportation costs (Baht)30,000.0 (5,000.0)17,875.0 (9,657.5)0.029*25,000.0 (-)Caregiver costs (Baht)40,000.0 (10,000.0)55,000.0 (29,760.9)0.24370,000.0 (-)Clothes-foods costs (Baht)30,000.0 (10,000.0)24,375.0 (10,500.9)0.46150,000.0 (-)Willingness to pay (Baht)60,000.0 (10,000.0)137,500.0 (148,203.5)0.184200,000.0 (-)Direct medical cost (Baht)28,465.0 (5,789.4)37,277.5 (6,822.1)0.09550,000.0 (-)Direct non-medical and indirect costs (Baht)100,000.0 (5,000.0)97,250.0 (42,060.3)0.861145,000.0 (-)Total costs (Baht)128,465.0 (10,496.1)134,527.5 (41,799.0)0.713195,000.0 (-)SD = standard deviation, *significant P-value < 0.05 comparing between hip spica and plate and screw fixation Resource utilization and costs for each treatment SD = standard deviation, *significant P-value < 0.05 comparing between hip spica and plate and screw fixation Subgroup analysis was performed by comparing HS and PS. The differences of direct medical costs, direct non- medical costs and total costs between both groups were − 8,812, 2,750 and − 6,062 Baht, respectively. When compared to PS, HS demonstrated lower costs and higher QALY with ICER for hospital perspective − 383,152 Baht/QALY and for societal perspective − 263,587 Baht/QALY (Table 3). One-way analysis also determined more effective and less expensive benefit of HS when compared to PS (Fig. 1). The tornado diagram revealed operation costs of PS and admission costs of both treatments mostly contributed to cost-utility pattern (Fig. 2). Table 3Subgroup analysis: hip spica cast versus plate and screws fixationCost utility analysis, mean (range)Hip spica cast(n = 3)Plate and screw fixation (n = 8)Difference(95% CI)Direct medical cost (Baht)28,465.0(24,810.0–35,140.0)37,277.5(27,765.0-48450.0)-8,812.5(-19,996.6–2,300.6)Direct non-medical and indirect cost (Baht)100,000.0(95,000.0-105,000.0)97,250.0(38,000.0-170,000.0)2,750.0(-32,591.1–38.091.1)Total cost (Baht)128,465.0(119,810.0-140,140.0)134,527.5(79,250.0-206,700.0)-6,062.5(-42,390.8–30.265.8)Quality of life (QALY)0.981(0.944-1)0.958(0.861-1)0.023(-0.040–0.086)ICER (Baht/QALY) Hospital perspective-383,152.2 (-869,417.4–100,026.1) Societal perspective-263,587.0 (-1,843,078.3–1,315,904.4)CI = confidence interval, QALY = quality adjusted life year, ICER = incremental cost-effectiveness ratio Table 3Subgroup analysis: hip spica cast versus plate and screws fixationCost utility analysis, mean (range)Hip spica cast(n = 3)Plate and screw fixation (n = 8)Difference(95% CI)Direct medical cost (Baht)28,465.0(24,810.0–35,140.0)37,277.5(27,765.0-48450.0)-8,812.5(-19,996.6–2,300.6)Direct non-medical and indirect cost (Baht)100,000.0(95,000.0-105,000.0)97,250.0(38,000.0-170,000.0)2,750.0(-32,591.1–38.091.1)Total cost (Baht)128,465.0(119,810.0-140,140.0)134,527.5(79,250.0-206,700.0)-6,062.5(-42,390.8–30.265.8)Quality of life (QALY)0.981(0.944-1)0.958(0.861-1)0.023(-0.040–0.086)ICER (Baht/QALY) Hospital perspective-383,152.2 (-869,417.4–100,026.1) Societal perspective-263,587.0 (-1,843,078.3–1,315,904.4)CI = confidence interval, QALY = quality adjusted life year, ICER = incremental cost-effectiveness ratio Subgroup analysis: hip spica cast versus plate and screws fixation 28,465.0 (24,810.0–35,140.0) 37,277.5 (27,765.0-48450.0) -8,812.5 (-19,996.6–2,300.6) 100,000.0 (95,000.0-105,000.0) 97,250.0 (38,000.0-170,000.0) 2,750.0 (-32,591.1–38.091.1) 128,465.0 (119,810.0-140,140.0) 134,527.5 (79,250.0-206,700.0) -6,062.5 (-42,390.8–30.265.8) 0.981 (0.944-1) 0.958 (0.861-1) 0.023 (-0.040–0.086) CI = confidence interval, QALY = quality adjusted life year, ICER = incremental cost-effectiveness ratio Discussion This study shows the cost utility of management for pediatric femoral fracture in the university hospital. No bony deformity or associated complication was detected in both groups. Costs incurred from HS was 128,465 Baht (119,810 − 140,140), and that of PS was 134,527 Baht (79,250 − 206,700). The former treatment produced higher utility (0.981, 0.944-1) when compared to the latter (0.958, 0.861-1). In comparison to PS, HS expended lower costs with commensurable QALYs in both hospital and societal perspectives. Admission and operation costs were major medical expenses of both treatments. Various therapeutic methods were proposed for pediatric femoral shaft fracture. The most common conservative treatment, in particular for patients aged 2–5 years old, was HS. PS, flexible intramedullary nailing, and EF were operative choices for patients aged 5–10 years old. The patient with simple femoral shaft fracture age 5–6 years old can be treated with HS or PS. From a network meta-analysis [8] comparing HS, PS, nailing, and EF, TENs could be the best interventions for pediatric femoral fractures in terms of union, joint stiffness, malunion, and infection rates. A systematic review and meta-analysis [9] reported higher loss of reduction, nonunion, and refracture from elastic stable intramedullary nailing than submuscular plating. The previous meta-analysis [10] among children aged 2–5 years old demonstrated superiority of flexible intramedullary nail over HS with regards to return to activities, malunion, and reoperation. On the contrary, nailing prolonged hospitalization, and demanded second surgery for hardware removal. These results were based on low to moderate quality studies without publication bias assessment. In our setting, small children may benefit from immediate HS for simple fractures. For juvenile or adolescent femoral fractures, PS may be suitable rather than highly cost/limited access to TEN. In real world, financial perspectives are still necessary to identify the most appropriate treatment. The cost analysis of this study favored HS to PS without noticeable complications. The explanation was mainly due to lower direct medical costs of HS (28,465 Baht, range 24,810 − 35,140 Baht) than PS (37,277 Baht, range 27,765-48450 Baht). Hip spica required additional transportation, clothes and foods costs. In contrast, PS consumed longer operative time, length of hospital stays and blood transfusion resulting in high costs of operation, admission, and caregivers. Hedin H, et al. [16] supported that treatment costs for pediatric femoral shaft fracture primarily depended on length of hospital stays. Expenses of implant, operation, hospitalization and caregivers were also influenced by costs of living in a specific context. Our costs of pediatric femoral fracture treatment were lower than other studies from developed countries. HS attributed to 128,465 Baht ($3,585), and total costs of PS was 134,527 Baht ($3,754). Total costs of the same HS in US year 1997 ($5,097) converted to present costs was up to $11,409 [15], and for hospital traction HS was $50,667 [16]. The hospital charges for immediate HS were reckoned from $5,494 [17] to $19,200 [18]. Contradictorily, total costs of traction HS vs. PS in Nigeria was only $124 ($194 at present) vs. $206 ($324 at present) [19]. The cost of PS accounted for implants, and antibiotics was 38% more expensive than 6-week prolonged traction HS. For EF, cost of treatment (one case with multiple injury) specifically acquired from operation, admission, radiographs, caregivers, food and clothes tended to be higher when compared to immediate HS. Previous studies [15, 16] from Sweden and Canada supported that radiographs, anesthesia, duration of hospital stays, out-patient clinic visits and also external fixator itself contributed to additional costs. Nowadays, there was no cost-utility analysis study in pediatric patients with femoral shaft fracture. This study indicated QALY of HS at 0.981 (0.944-1) compared to that of PS at 0.958 (0.861-1), and EF at 0.944. Cost utility analysis demonstrated 130,953.1 Baht/QALY for HS, and 140,425.4 Baht/QALY for PS. In Thailand, osteoporosis hip fracture utilized 231,466 Baht/QALY [28], equivalent to the GDP per capita (247,239 Baht). Comparatively, HS, and PS consumed at least 0.530, and 0.568 time of GDP per capita to gain 1 QALY, respectively. Moreover, willingness to pay for PS (137,500 Baht) was correspondingly 2 times higher than that of HS (60,000 Baht). Within this small cohort, HS demonstrated lower mean costs and comparable QALYs to PS; larger multi-centred studies are warranted to confirm these findings. Cost and utility estimates for EF (n = 1) should be interpreted cautiously and primarily serve to illustrate methodological feasibility. The strengths of this study are incorporated costs and QALYs to determine proper cost-utility analysis. Direct medical costs essentially captured admission, operation and radiographs. Three treatments for pediatric femoral shaft fractures, indirect costs, and willingness to pay was considered. All direct medical, non-medical, and indirect costs were appraised for societal-perspective total cost estimation. ICER were analyzed and factors attributed to cost-utility were generated as a Tornado diagram. There are several limitations in this study. First, the single-center ambi-directional study encounters with recall and selection biases as well as impacts the study applicability. Second, small sample size (especially HS and EF groups) constrains validity of the results, and power to identify significant differences of baseline characteristics, costs, QALYs, and complications between treatments. Post hoc power calculation based on the actual samples (HS = 3 cases, PS = 8 cases) and direct ICER results (383,152.2 ± 242,360.9 Baht/QALY) is 0.646. Inadequate power of this study from type II error consequently leads to insignificant P-value. Third, only HS, PS, and EF were taken into account leading to limited generalizability to other fixation such as submuscular plating, intramedullary nailing. Fourth, a direct non-medical cost may be confounded by socioeconomic status, and family burden. A large prospective study that includes other choices of treatment in the same age range is needed to estimate the valid ICER. For clinical applications among middle income countries, HS provided better cost-utility than PS among pediatric femoral shaft fracture, aged 4–14 years old. Its generalizability is with great caution because of different methodology, health and socioeconomic context. Conclusion According to treatments of pediatric femoral shaft fractures, HS allows more cost saving and prefers utility to PS. This information may help in preoperative planning or making treatment decisions which concern both cost of treatment and quality of life of the patient. Nevertheless, the most proper management based on age, fracture pattern, and also socioeconomic context. Future large-scale randomized controlled trials comparing various therapeutic methods in different settings would deliver the best option for specific population. Fig. 1Cost-effectiveness plane comparing the incremental cost-effectiveness ratio (ICER) of hip spica to plate and screw fixation, QALY = quality adjusted life year Cost-effectiveness plane comparing the incremental cost-effectiveness ratio (ICER) of hip spica to plate and screw fixation, QALY = quality adjusted life year Fig. 2Tornado diagram displayed a scale of the incremental cost-effectiveness ratio (ICER) variation. Each bar characterized base value (at a vertical line), and range of incurred costs that influenced ICER. With regards to the widest bar, operation costs of plate and screw (PS) followed by admission costs of hip spica (HS) and PS mostly contributed to ICER uncertainty. PS = plate and screw, HS = hip spica, ICER = incremental cost-effectiveness ratio, values in Baht/quality adjusted life year (QALY) Tornado diagram displayed a scale of the incremental cost-effectiveness ratio (ICER) variation. Each bar characterized base value (at a vertical line), and range of incurred costs that influenced ICER. With regards to the widest bar, operation costs of plate and screw (PS) followed by admission costs of hip spica (HS) and PS mostly contributed to ICER uncertainty. PS = plate and screw, HS = hip spica, ICER = incremental cost-effectiveness ratio, values in Baht/quality adjusted life year (QALY)